Cushing's Disease Management: Glimpse Into 2051

Rinkoo Dalan; Stefan R Bornstein; Bernhard O Boehm

doi:10.3389/fendo.2022.943993

Cushing's Disease Management: Glimpse Into 2051

Front Endocrinol (Lausanne). 2022 Jul 6:13:943993. doi: 10.3389/fendo.2022.943993. eCollection 2022.

Authors

Rinkoo Dalan^{1

2}, Stefan R Bornstein^{2

3

4

5}, Bernhard O Boehm²

Affiliations

¹ Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore.
² Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
³ Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
⁴ Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
⁵ Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital, Zürich, Switzerland.

Abstract

Major advancements are expected in medicine and healthcare in the 21st century- "Digital Age", mainly due to the application of data technologies and artificial intelligence into healthcare. In this perspective article we share a short story depicting the future Cushings' Disease patient and the postulated diagnostic and management approaches. In the discussion, we explain the advances in recent times which makes this future state plausible. We postulate that endocrinology care will be completely reinvented in the Digital Age.

Keywords: Cushings disease; circadian rhythms; digital; future; technology development.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Artificial Intelligence
Endocrinology*
Humans
Pituitary ACTH Hypersecretion* / diagnosis
Pituitary ACTH Hypersecretion* / therapy